---
title: "Real-World Marijuana Use Linked to Altered Nocturnal Cardiac Autonomic Function and Poorer Sleep"
id: "medrxiv-15-real-world-marijuana-use-is-associated-with-altered-nocturnal-cardiac-autonomic"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-15-real-world-marijuana-use-is-associated-with-altered-nocturnal-cardiac-autonomic"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.15.26363138v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Real-World Marijuana Use Linked to Altered Nocturnal Cardiac Autonomic Function and Poorer Sleep
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-15-real-world-marijuana-use-is-associated-with-altered-nocturnal-cardiac-autonomic
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.15.26363138v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This large wearable-based study analyzed 5,226,739 person-days from 16,965 users to assess associations between real-world **marijuana** use, nocturnal cardiac autonomic function, and sleep. - Participants self-reported daily marijuana use while wearing a consumer wearable; the dataset captured heart rate, heart rate variability, and sleep metrics over weeks to months. - Median reported marijuana use occurred on 25.1% of logged days (IQR 7.1–62.6%). - Within individuals, nights with marijuana use were associated with a small decrease in nocturnal resting heart rate (RHR) of −0.12 bpm (99.5% CI −0.14 to −0.10). - Use nights were also associated with lower heart rate variability (HRV), with a within-person difference of −0.47 ms (99.5% CI −0.53 to −0.42), indicating altered autonomic modulation. - Sleep duration was longer on use nights by +7.60 minutes (99.5% CI 7.37 to 7.83), but sleep quality was reduced: increased fragmentation (+0.47 disturbances [0.45, 0.48]) and greater wake time (+1.79 minutes [1.70, 1.89]). - Wearable-estimated sleep architecture also differed on use nights, though specific architecture details beyond alteration were reported generally in the source. - Probability of daily marijuana use declined over 72 weeks of tracking by −11.1% (99.5% CI −11.5 to −10.8%), suggesting consumption decreased during longitudinal self-monitoring. - Authors note potential for consumer wearables to extend laboratory findings to naturalistic settings and to study substance use physiology at scale. - Competing interests: all listed authors are employees of WHOOP, Inc., the wearable manufacturer; WHOOP provided salary support and data infrastructure. Data access is restricted and available on request per WHOOP procedures.
## Clinical Analysis & Structured Key Points
Real-World Marijuana Use Is Associated With Altered Nocturnal Cardiac Autonomic Function, Reduced Sleep Quality, and Declining Consumption During Wearable Monitoring | medRxiv Skip to main content Real-World Marijuana Use Is Associated With Altered Nocturnal Cardiac Autonomic Function, Reduced Sleep Quality, and Declining Consumption During Wearable Monitoring View ORCID Profile Dylan Curran , View ORCID Profile William von Hippel , View ORCID Profile Finnbarr Fielding , View ORCID Profile Summer R Jasinski , View ORCID Profile Josh Leota , View ORCID Profile Jenna G Cohen , View ORCID Profile Kristen E Holmes , View ORCID Profile Gregory J Grosicki , View ORCID Profile Christian P Cheung doi: https://doi.org/10.64898/2026.09.15.26363138 Dylan Curran 1 WHOOP Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Dylan Curran William von Hippel 2 WHOOP Inc Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for William von Hippel Finnbarr Fielding 2 WHOOP Inc Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Finnbarr Fielding Summer R Jasinski 1 WHOOP Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Summer R Jasinski Josh Leota 2 WHOOP Inc Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Josh Leota Jenna G Cohen 1 WHOOP Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jenna G Cohen Kristen E Holmes 1 WHOOP Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kristen E Holmes Gregory J Grosicki 1 WHOOP Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Gregory J Grosicki Christian P Cheung 1 WHOOP Inc.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Christian P Cheung For correspondence: christian.cheung{at}whoop.com Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Marijuana is among the most widely used controlled substances, with use rising as risk perception declines. Despite growing acceptance, concerns remain regarding its effects on cardiovascular and autonomic physiology, sleep, and risk of cannabis use disorder. Although laboratory and epidemiological studies have characterized these associations, objective evidence from real-world settings is limited. Methods We studied cardiac autonomic function, sleep, and marijuana use patterns in 16,965 consumer-wearable device users, contributing a total of 5,226,739 person-days of data with or without self-reported use of marijuana. Linear mixed models related day-level use to nocturnal cardiac autonomic function (resting heart rate [RHR], heart rate variability [HRV]) and sleep (duration, fragmentation, architecture) at the within- and between-person levels. Binomial mixed models were used to estimate use probability across 72 weeks of marijuana tracking. Results: Members reported marijuana use on a median of 25.1% of logged days (IQR, 7.1-62.6%). Within individuals, use was associated with lower RHR (-0.12bpm; 99.5% CI: [-0.14, -0.10]) and lower HRV (-0.47ms [-0.53, -0.42]). Sleep was longer (+7.60min [7.37, 7.83]) but more fragmented, with more disturbances (+0.47 [0.45, 0.48]), greater wake time (+1.79min [1.70, 1.89]), and altered wearable-estimated sleep architecture. Daily use probability declined over 72 weeks (-11.1% [-11.5, -10.8]). Conclusions: Marijuana use was associated with altered nocturnal cardiac autonomic physiology and longer but more disrupted sleep. Marijuana use declined after commencing tracking, raising the possibility that longitudinal self-monitoring may influence use. These findings extend laboratory evidence on marijuana use to real-world settings and demonstrate the potential of consumer wearables for studying substance use and its physiological correlates at scale. Competing Interest Statement Authors DC, WvH, FF, SRJ, JL, JGC, KEH, GJG and CPC are employees of WHOOP, Inc., the manufacturer of the wearable device used in this study, and are granted stock options as part of their standard employee compensation package. WHOOP, Inc. provided salary support and data infrastructure for this work. Marketing, enterprise, and other non-research groups at WHOOP, Inc. had no role in study approval, data interpretation, manuscript preparation, or decisions regarding submission or publication. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: All participants consent to the use of their deidentified data for research purposes when they join the platform and are given the opportunity to revoke consent and have their data deleted at any time. The study protocol was reviewed and approved by an independent institutional review board (Salus Institutional Review Board; approval number 251121). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The participant data are not publicly available due to intellectual property concerns of WHOOP, Inc. Deidentified participant data and a data dictionary may be made available upon reasonable request to WHOOP (via science{at}whoop.com). Access requires submission of a methodologically sound proposal, approved by WHOOP's research team, and a signed data use agreement. Requests will receive a response within 4 weeks. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Real-World Marijuana Use Is Associated With Altered Nocturnal Cardiac Autonomic Function, Reduced Sleep Quality, and Declining Consumption During Wearable Monitoring Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Real-World Marijuana Use Is Associated With Altered Nocturnal Cardiac Autonomic Function, Reduced Sleep Quality, and Declining Consumption During Wearable Monitoring Dylan Curran , William von Hippel , Finnbarr Fielding , Summer R Jasinski , Josh Leota , Jenna G Cohen , Kristen E Holmes , Gregory J Grosicki , Christian P Cheung medRxiv 2026.09.15.26363138; doi: https://doi.org/10.64898/2026.09.15.26363138 Share This Article: Copy Citation Tools Real-World Marijuana Use Is Associated With Altered Nocturnal Cardiac Autonomic Function, Reduced Sleep Quality, and Declining Consumption During Wearable Monitoring Dylan Curran , William von Hippel , Finnbarr Fielding , Summer R Jasinski , Josh Leota , Jenna G Cohen , Kristen E Holmes , Gregory J Grosicki , Christian P Cheung medRxiv 2026.09.15.26363138; doi: https://doi.org/10.64898/2026.09.15.26363138 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Epidemiology Subject Areas All Articles Addiction Medicine (618) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4825) Dentistry and Oral Medicine (479) Dermatology (418) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15966) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7060) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5058) Health Policy (1436) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16302) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7290) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3613) Ophthalmology (1054) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (738) Primary Care Research (768) Psychiatry and Clinical Psychology (5915) Public and Global Health (9769) Radiology and Imaging (2430) Rehabilitation Medicine and Physical Therapy (1455) Respiratory Medicine (1249) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (578) Surgery (781) Toxicology (107) Transplantation (305) Urology (292)
## Related Clinical Research

- [Insulin promotes RAGE ectodomain shedding via AKT‑ and Rab14‑dependent ADAM10 trafficking in HAECs](https://medichelpline.com/clinical-feed/plos-one-22-insulin-enhances-rage-ectodomain-shedding-by-inducing-rab14-dependent-adam10.md)
- [Fish oil plus metformin for vascular and cardiac health in women with PMOS: protocol for a randomi](https://medichelpline.com/clinical-feed/bmj-open-6-effect-of-fish-oil-as-an-adjunct-therapy-to-metformin-on-vascular-and-cardiac.md)
- [Gut Microbiome Biomarkers Associated with Primary VT/VF in STEMI Identified by Machine Learning](https://medichelpline.com/clinical-feed/medrxiv-22-machine-learning-approach-to-identify-gut-microbiota-biomarkers-in-patients.md)
- [MyoSTAT.AI: Reproducible AI Toolkit for Myocardial Stiffness Tracking and Shear‑Wave Velocity Stab](https://medichelpline.com/clinical-feed/medrxiv-5-myocardial-stiffness-tracking-assessment-toolkit-driven-by-artificial.md)
- [Retinal changes on OCT may predict atrial fibrillation risk years before diagnosis](https://medichelpline.com/clinical-feed/medical-news-today-0-how-changes-in-the-eyes-may-help-spot-afib-risk-years-early.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.